Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study

BackgroundPatients who have recently received a hematopoietic cell transplant (HCT) are at higher risk of acute complications in the first weeks after discharge, especially during the COVID-19 pandemic. ObjectiveThe aim of this study was to test the use of a teleh...

Full description

Bibliographic Details
Main Authors: Mussetti, Alberto, Salas, Maria Queralt, Condom, Maria, Antonio, Maite, Ochoa, Cristian, Ivan, Iulia, Jimenez Ruiz-De la Torre, David, Sanz Linares, Gabriela, Ansoleaga, Belen, Patiño-Gutierrez, Beatriz, Jimenez-Prat, Laura, Parody, Rocio, Sureda-Balari, Ana
Format: Article
Language:English
Published: JMIR Publications 2021-03-01
Series:JMIR Formative Research
Online Access:https://formative.jmir.org/2021/3/e26121
id doaj-5e1c398c8b654744b736f1ad7e9eaa47
record_format Article
spelling doaj-5e1c398c8b654744b736f1ad7e9eaa472021-04-02T20:55:04ZengJMIR PublicationsJMIR Formative Research2561-326X2021-03-0153e2612110.2196/26121Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot StudyMussetti, AlbertoSalas, Maria QueraltCondom, MariaAntonio, MaiteOchoa, CristianIvan, IuliaJimenez Ruiz-De la Torre, DavidSanz Linares, GabrielaAnsoleaga, BelenPatiño-Gutierrez, BeatrizJimenez-Prat, LauraParody, RocioSureda-Balari, Ana BackgroundPatients who have recently received a hematopoietic cell transplant (HCT) are at higher risk of acute complications in the first weeks after discharge, especially during the COVID-19 pandemic. ObjectiveThe aim of this study was to test the use of a telehealth platform for the follow-up of HCT patients during the first two weeks after discharge. MethodsIn total, 21 patients who received autologous or allogeneic HCT for hematological malignancies were screened from April 30, 2020, to July 15, 2020. The telehealth platform assisted in the daily collection of vital signs as well as physical and psychological symptoms for two weeks after hospital discharge. The required medical devices (oximeter and blood pressure monitor) were given to patients and a dedicated smartphone app was developed to collect this data. The data were reviewed daily through web-based software by a hematologist specializing in HCT. ResultsOnly 12 of 21 patients were able to join and complete the study. Technological barriers were the most frequent limiting factor in this study. Among the 12 patients who completed the study, adherence to data reporting was high. The patients’ experience of using such a system was considered good. In two cases, the system enabled the early recognition of acute complications. ConclusionsThis pilot study showed that telehealth systems can be applied in the early posttransplant setting, with evident advantages for physicians and patients for both medical and psychological aspects. Technological issues still represent a challenge for the applicability of such a system, especially for older adult patients. Easier-to-use technologies could help to expand the use of telehealth systems in this setting in the future.https://formative.jmir.org/2021/3/e26121
collection DOAJ
language English
format Article
sources DOAJ
author Mussetti, Alberto
Salas, Maria Queralt
Condom, Maria
Antonio, Maite
Ochoa, Cristian
Ivan, Iulia
Jimenez Ruiz-De la Torre, David
Sanz Linares, Gabriela
Ansoleaga, Belen
Patiño-Gutierrez, Beatriz
Jimenez-Prat, Laura
Parody, Rocio
Sureda-Balari, Ana
spellingShingle Mussetti, Alberto
Salas, Maria Queralt
Condom, Maria
Antonio, Maite
Ochoa, Cristian
Ivan, Iulia
Jimenez Ruiz-De la Torre, David
Sanz Linares, Gabriela
Ansoleaga, Belen
Patiño-Gutierrez, Beatriz
Jimenez-Prat, Laura
Parody, Rocio
Sureda-Balari, Ana
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
JMIR Formative Research
author_facet Mussetti, Alberto
Salas, Maria Queralt
Condom, Maria
Antonio, Maite
Ochoa, Cristian
Ivan, Iulia
Jimenez Ruiz-De la Torre, David
Sanz Linares, Gabriela
Ansoleaga, Belen
Patiño-Gutierrez, Beatriz
Jimenez-Prat, Laura
Parody, Rocio
Sureda-Balari, Ana
author_sort Mussetti, Alberto
title Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
title_short Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
title_full Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
title_fullStr Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
title_full_unstemmed Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
title_sort use of telehealth for domiciliary follow-up after hematopoietic cell transplantation during the covid-19 pandemic: prospective pilot study
publisher JMIR Publications
series JMIR Formative Research
issn 2561-326X
publishDate 2021-03-01
description BackgroundPatients who have recently received a hematopoietic cell transplant (HCT) are at higher risk of acute complications in the first weeks after discharge, especially during the COVID-19 pandemic. ObjectiveThe aim of this study was to test the use of a telehealth platform for the follow-up of HCT patients during the first two weeks after discharge. MethodsIn total, 21 patients who received autologous or allogeneic HCT for hematological malignancies were screened from April 30, 2020, to July 15, 2020. The telehealth platform assisted in the daily collection of vital signs as well as physical and psychological symptoms for two weeks after hospital discharge. The required medical devices (oximeter and blood pressure monitor) were given to patients and a dedicated smartphone app was developed to collect this data. The data were reviewed daily through web-based software by a hematologist specializing in HCT. ResultsOnly 12 of 21 patients were able to join and complete the study. Technological barriers were the most frequent limiting factor in this study. Among the 12 patients who completed the study, adherence to data reporting was high. The patients’ experience of using such a system was considered good. In two cases, the system enabled the early recognition of acute complications. ConclusionsThis pilot study showed that telehealth systems can be applied in the early posttransplant setting, with evident advantages for physicians and patients for both medical and psychological aspects. Technological issues still represent a challenge for the applicability of such a system, especially for older adult patients. Easier-to-use technologies could help to expand the use of telehealth systems in this setting in the future.
url https://formative.jmir.org/2021/3/e26121
work_keys_str_mv AT mussettialberto useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT salasmariaqueralt useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT condommaria useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT antoniomaite useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT ochoacristian useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT ivaniulia useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT jimenezruizdelatorredavid useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT sanzlinaresgabriela useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT ansoleagabelen useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT patinogutierrezbeatriz useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT jimenezpratlaura useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT parodyrocio useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
AT suredabalariana useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy
_version_ 1721546224989896704